Alternative treatment strategies for catatonia: A systematic review

Gen Hosp Psychiatry. 2017 Sep:48:1-19. doi: 10.1016/j.genhosppsych.2017.06.011. Epub 2017 Jun 24.

Abstract

Background: Catatonia is a commonly encountered syndrome, affecting 10-20% of various psychiatric populations and carrying significant medical co-morbidities. However, there are few established alternative treatment strategies when benzodiazepines are ineffective and electroconvulsive therapy is unavailable.

Objective: The authors systematically review evidence for alternative treatment strategies for catatonia using Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines.

Method: The authors conducted a search of PubMed database from 1983 to August 2016 to identify articles. Eligible reports presented cases involving treatment of catatonia using modalities other than benzodiazepines or electroconvulsive therapy.

Results: The authors identified 72 articles, comprising 98 individual cases. N-methyl-d-aspartate-receptor antagonists, anti-epileptic drugs, and atypical antipsychotic agents appeared to have the largest number of reports supporting their effectiveness and safety in treating catatonia patients.

Conclusions: Based on the case report literature, the authors propose an updated algorithm for catatonia treatment in cases where benzodiazepines fail and electroconvulsive therapy is not available.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Anticonvulsants / therapeutic use*
  • Antipsychotic Agents / therapeutic use*
  • Catatonia / drug therapy*
  • Humans
  • Receptors, N-Methyl-D-Aspartate / antagonists & inhibitors*

Substances

  • Anticonvulsants
  • Antipsychotic Agents
  • Receptors, N-Methyl-D-Aspartate